22098-10-8 Usage
General Description
Ethyl (5-bromothien-2-yl)glyoxylate is a chemical compound with a unique structure composed of a thiophene ring, a bromine atom, an ethyl group, and a glyoxylate group. The thiophene entity, known for aromatic properties, provides stability to the compound. The bromine atom has the ability to participate in halogen bonding, which could be important in certain chemical reactions. The ethyl group is a common alkyl component in a variety of organic compounds, and the glyoxylate group contains both a carbonyl and a carboxyl group, which may lend the compound potential reactivity in certain chemical transformations. ETHYL (5-BROMOTHIEN-2-YL)GLYOXYLATE could be utilized in various chemical synthesis applications, due to its complex structural composition. However, specifics about its reactivity and potential uses are typically determined through experimental studies. As with all chemicals, adequate safety measures should be taken while handling Ethyl (5-bromothien-2-yl)glyoxylate.
Check Digit Verification of cas no
The CAS Registry Mumber 22098-10-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,0,9 and 8 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 22098-10:
(7*2)+(6*2)+(5*0)+(4*9)+(3*8)+(2*1)+(1*0)=88
88 % 10 = 8
So 22098-10-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H7BrO3S/c1-2-12-8(11)7(10)5-3-4-6(9)13-5/h3-4H,2H2,1H3
22098-10-8Relevant articles and documents
Substituted cis-3,3,5-trimethylcyclohexyl thienylglycolates
Unterhalt,Gores
, p. 839 - 840 (1989)
-
PYRIMIDINE COMPOUNDS AS TUBERCULOSIS INHIBITORS
-
Page/Page column 193, (2011/02/24)
The present invention relates to compounds II useful as inhibitors of treating tuberculosis. The invention also provides processes for preparing compounds of the invention.
Synthesis and receptor affinities of new 3-quinuclidinyl α-heteroaryl-α- aryl-α-hydroxyacetates
Cohen,Gibson,Fan,De la Cruz,Gitler,Hariman,Reba
, p. 326 - 329 (2007/10/02)
Five analogues of 3-quinuclidinyl benzilate were prepared in which one phenyl ring was substituted by a heterocycle; a bromine was included on either the remaining phenyl or the heterocycle to provide information relating to the affinity of potential radiohalogenated derivatives. Their affinities for the muscarinic cholinergic receptor were determined. Replacing a phenyl ring with either the 2- or 3-furyl moiety or the 2- or 3-thienyl moiety did not significantly alter the affinity to the muscarinic receptor compared with 3-quinuclidinyl 4-bromobenzilate.